トップページ  > 研究業績(三宅)

2013年- 研究業績

2012-2010 2009-2007 2006-2004 2003-2001 2000以前


1) Chihara N, Aranami T, Oki S, Matsuoka T, Nakamura M, Kishida H, Yokoyama K, Kuroiwa Y, Hattori N, Okamaoto T, Murata M, Toda T, Miyake S, Yamamura T. Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. PLOS one, 2013 Dec 10;8(12):e83036

2) Di Penta A, Chiba A, Alloza I, Wyssenbach A, Yamamura T, Villoslada P, Miyake S, Vandenbroeck K. A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. PLOS one, 2013 Dec 11;8(12):e83119

3) Noto D, Sakuma H, Takahashi K, Yamada M, Yamamura T, Miyake S. Development of a culture system to induce microglia-like cells from hematopoietic cells. Neuropathol Appl Neurobiol, 2014 Oct;40(6):697-713.

4) Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M, Miyake S, Aranami T, Yamamura T. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neruomyelitis optica:A pilot study. Neurology, 2014 Apr 15;82(15):1302-6.

5) Kamachi F, Harada N, Usui Y, Sakanishi T, Ishii N, Okumura K, Miyake S, Akiba H. OX40 ligand regulates splenic CD8 dendritic cell-induced Th2h responses in vivo. Biochem Biophys Res Commun, 2014 Feb 7;444(2):235-40.

6) Nakamura M, Matsuoka T, Chihara N, Miyake S, Sato W, Araki M, Okamoto T, Lin Y, Ogawa M, Murata M, Aranami T, Yamamura T. Differential effects of fingolimod on B-cell populations in multiple sclerosis. Mult Scler, 2014 Sep;20(10):1371-80.

7) Chiba A, Miyake S. Basic Techniques for Studies of iNKT Cells and MAIT Cells. Methods Mol Biol, 2014;1142:75-84.

8) Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun, 2015 Aug 7;463(4):739-45.

9) Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One, 2015 Sep 14;10(9):e0137429.

10) Takenaka S-I, Kaieda S, Kawayama T, Matsuoka M, Kaku Y, Kinoshita T, Sakazaki Y, Okamoto M, Tominaga M, Kanesaki K, Chiba A, Miyake S, Ida H, Hoshino T. IL-38: A new factor in rheumatoid arthritis. Biochemistry and Biophysics Reports, 2015;4:386-391.

11) Haga K, Chiba A, Shibuya T, Osada T, Ishikawa D, Kodani T, Nomura O, Watanabe S, Miyake S. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. J Gastroenterol Hepatol, 2016;31(5):965-72.

12) Kadowaki A, Miyake S, Saga R, Chiba A, Mochizuki H, Yamamura T. Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3. Nature Communications, 2016;7:11639.

13) Hayashi E, Chiba A, Tada k, Haga K, Kitagaichi M, Nakajima S, Kusaoi M, Sekiya F, Ogasawara M, Yamaji K, Tamura N, Takasaki Y, Miyake S. Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis. Journal of Rheumatology, 2016;43(9):1695-1703.

14) Ishimori A, Harada N, Chiba A, Harada S, Matsuno K, Makino F, Ito J, Ohta S, Ono Junya, Atsuta R, Izuhara K, Takahashi K, Miyake S. Circulationg activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma. Allergology International, 2016. [in press]

15) Chiba A, Tamura N, Yoshikiyo K, Murayama G, Kitagaichi M, Yamaji K, Takasaki Y, Miyake S. Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus. Arthritis Res Ther, 2017 Mar 14;19(1):58.

16) Mizuno M, Noto D, Kaga N, Chiba A, Miyake S. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS One, 2017 Feb 24;12(2):e0173032.


Copyright c 2013 JUNTENDO All Rights Reserved.